{"disease":{"id":"synucleinopathy","name":"synucleinopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07480187","title":"Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":340,"lead_sponsor_name":"Azienda Ospedaliera di Perugia","has_results":false},{"nct_id":"NCT06745011","title":"Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06738862","title":"[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients","phase":"","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT04534023","title":"A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06445465","title":"Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Invicro","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}